Results 61 to 70 of about 50,432 (266)
The Drug-Eluting Stent Saga [PDF]
Circulation, 2009 Drug-eluting stents (DES) represent a breakthrough technology owing to their potent reduction of restenosis, which is a nuisance in the quality of life of affected patients, a rare cause of myocardial infarction (MI), and the principal shortcoming of stents compared with coronary artery bypass surgery.
Stephan Windecker, Peter Jüni
openaire +2 more sources
Artificial intelligence‐assisted design, synthesis and analysis of smart biomaterials
BMEMat, EarlyView.Smart biomaterials are rapidly emerging as tools for tissue engineering, and artificial intelligence has played essential roles in biomaterial studies. By bridging the literature gap in AI‐based design, synthesis and analysis of smart biomaterials, the current review shares perspectives on how biomaterial scientists can practically incorporate AI for ...
Pengfei Jiang +9 more
wiley +1 more source
Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach
Journal of Cardiothoracic Surgery, 2022 Background Introduction of Bare Metal Stents (BMS) was itself a revolutionary step in the history of the medical industry; however, Drug Eluting Stents (DES) maintained its superiority over BMS in every aspect from restenosis rate to late lumen loss. The
Sadia Hassan +2 more
doaj +1 more source
Role of noncoding RNA in vascular remodelling [PDF]
, 2016 Purpose of review: Noncoding RNAs (ncRNAs), such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) are becoming fundamentally important in the pathophysiology relating to injury-induced vascular remodelling.
Baker, Andrew H. +2 more
core +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Pseudoaneurysm (PA) is a well‐known vascular complication following percutaneous interventions, typically occurring in the early post‐procedural period. However, delayed‐onset PA associated with deep vein thrombosis (DVT) is an uncommon presentation.
Sefa Tatar +3 more
wiley +1 more source
Thrombosis prevention in percutaneous coronary interventions
Кардиоваскулярная терапия и профилактика, 2009 The introduction of drug-eluting stents has been a major achievement of interventional cardiology. These stents demonstrate good clinical effectiveness and safety profile.
V. P. Lupanov, A. N. Samko
doaj
Zotarolimus-eluting stent fracture at initial implantation diagnosed with StentBoost
SAGE Open Medical Case Reports, 2016 Stent fracture is a rare complication of drug-eluting stent implantation with a reported rate of 0.84%–3.2% in various clinical studies with first-generation drug-eluting stents and 29% in autopsy studies.
Alev Arat Ozkan +2 more
doaj +1 more source
Multifunctional star-shaped polylactic acid implants for use in angioplasty [PDF]
, 2014 Star-shaped polylactic acids with different tacticity were synthesized and both polymers are capable of bestowing properties of anticoagulation and angiogenesis to their living host.
Kiran, M. S. +3 more
core +2 more sources
Left Main PCI During Cardiac Arrest With Ongoing Lucas CPR
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Percutaneous coronary intervention (PCI) during cardiac arrest presents significant procedural challenges, particularly due to poor imaging and hemodynamic instability. We present the case of a 75‐year‐old man with worsening angina despite optimal medical therapy, who underwent PCI of the left anterior descending (LAD) artery.
Syed Yaseen Naqvi, Syed Mohammad Naqvi
wiley +1 more source
Long-term effectiveness and safety of sirolimus drug-eluting stents
Medical Devices: Evidence and Research, 2011 Mahesh Bikkina, Jayanth KoneruSt Joseph Regional Medical Center, Paterson, Seton Hall University, NJ, USAAbstract: The root cause of coronary artery disease is atherosclerosis, ie, intraluminal narrowing (stenosis) of the arteries that supply blood to ...
Bikkina M, Koneru J
doaj